1.Toxocariasis and multiple sclerosis: A case-control study in Iran
Mohammad Zibaei ; Behnaz Ghorbani
Neurology Asia 2014;19(3):283-286
Human toxocariasis is a zoonotic infection caused by the larval stage of Toxocara species. A
relationship between toxocariasis and multiple sclerosis has been hypothesized. In this study, we
aimed at investigating the frequency of Toxocara infection among multiple sclerosis patients and the
epidemiological factors associated with disease. Sixty-eight patients with multiple sclerosis and 70
healthy subjects were studied. Anti-Toxocara antibodies status was determined in all serum samples,
using ELISA technique. The frequency of Toxocara infection was found to be significantly higher in
multiple sclerosis patients as compared to the healthy control (14.7%, 1.4%, respectively) (P=0.004).
There was no significant difference between multiple sclerosis patients and control group in age,
education, and gender (P>0.05). This study indicates that a significant association between Toxocara
seropositivity and multiple sclerosis. Our finding suggests that toxocariasis infection may increase
the risk of multiple sclerosis.
2.Common conditions associated with displacement of the inferior alveolar nerve canal: A radiographic diagnostic aid
Hamed MORTAZAVI ; Maryam BAHARVAND ; Yaser SAFI ; Mohammad BEHNAZ
Imaging Science in Dentistry 2019;49(2):79-86
PURPOSE: This study reviewed the common conditions associated with displacement of inferior alveolar nerve canal. MATERIALS AND METHODS: General search engines and specialized databases including Google Scholar, Pub Med, Pub Med Central, Science Direct, and Scopus were used to find relevant studies by using keywords such as “mandibular canal”, “alveolar canal”, “inferior alveolar nerve canal”, “inferior dental canal”, “inferior mandibular canal” and “displacement”. RESULTS: About 120 articles were found, of which approximately 70 were broadly relevant to the topic. We ultimately included 37 articles that were closely related to the topic of interest. When the data were compiled, the following 8 lesions were found to have a relationship with displacement of mandibular canal: radicular/residual cysts, dentigerous cyst, odontogenic keratocyst, aneurysmal bone cyst, ameloblastoma, central giant cell granuloma, fibrous dysplasis, and cementossifying fibroma. CONCLUSION: When clinicians encounter a lesion associated with displaced mandibular canal, they should first consider these entities in the differential diagnosis. This review would help dentists make more accurate diagnoses and develop better treatment plans according to patients' radiographs.
Ameloblastoma
;
Aneurysm
;
Bone Cysts
;
Dentigerous Cyst
;
Dentists
;
Diagnosis
;
Diagnosis, Differential
;
Fibroma
;
Granuloma, Giant Cell
;
Humans
;
Mandibular Nerve
;
Odontogenic Cysts
;
Odontogenic Tumors
;
Search Engine
3.Common conditions associated with mandibular canal widening: A literature review
Hamed MORTAZAVI ; Maryam BAHARVAND ; Yaser SAFI ; Kazem DALAIE ; Mohammad BEHNAZ ; Fatemeh SAFARI
Imaging Science in Dentistry 2019;49(2):87-95
PURPOSE: The aim of this study was to review the common conditions associated with mandibular canal widening. MATERIALS AND METHODS: General search engines and specialized databases including Google Scholar, PubMed, PubMed Central, Science Direct, and Scopus were used to find relevant studies by using the following keywords: “mandibular canal,” “alveolar canal,” “inferior alveolar nerve canal,” “inferior dental canal,” “inferior mandibular canal,” “widening,” “enlargement,” “distension,” “expansion,” and “dilation.” RESULTS: In total, 130 articles were found, of which 80 were broadly relevant to the topic. We ultimately included 38 articles that were closely related to the topic of interest. When the data were compiled, the following 7 lesions were found to have a relationship with mandibular canal widening: non-Hodgkin lymphoma, osteosarcoma, schwannoma, neurofibroma, vascular malformation/hemangioma, multiple endocrine neoplasia syndromes, and perineural spreading or invasion. CONCLUSION: When clinicians encounter a lesion associated with mandibular canal widening, they should immediately consider these entities in the differential diagnosis. Doing so will help dentists make more accurate diagnoses and develop better treatment plans based on patients' radiographs.
Dentists
;
Diagnosis
;
Diagnosis, Differential
;
Humans
;
Lymphoma, Non-Hodgkin
;
Mandibular Nerve
;
Multiple Endocrine Neoplasia
;
Neurilemmoma
;
Neurofibroma
;
Odontogenic Cysts
;
Odontogenic Tumors
;
Osteosarcoma
;
Search Engine
4.Strongyloides stercoralis and other intestinal parasites in patients receiving immunosuppressive drugs in northern Iran: a closer look at risk factors
Leila MIRZAEI ; Keyhan ASHRAFI ; Zahra ATRKAR ROUSHAN ; Mohammad Reza MAHMOUDI ; Irandokht SHENAVAR MASOOLEH ; Behnaz RAHMATI ; Farshid SAADAT ; Hamed MIRJALALI ; Meysam SHARIFDINI
Epidemiology and Health 2021;43(1):e2021009-
OBJECTIVES:
The objective of this study was to evaluate the prevalence of Strongyloides stercoralis and other intestinal parasites in patients receiving immunosuppressive drugs in northern Iran and to investigate related risk factors.
METHODS:
This cross-sectional study was conducted among 494 patients receiving immunosuppressive drugs, including cancer patients undergoing chemotherapy (n=188) and those treated with prolonged corticosteroid administration (n=306). All fresh fecal samples were examined using the direct wet-mount, formalin ethyl acetate concentration, and agar plate culture techniques.
RESULTS:
In total, 16.8% of patients were positive for at least 1 intestinal parasite; the helminthic and protozoan infection rates were 5.1% and 12.3%, respectively. The infection rate was significantly higher in corticosteroid-treated individuals (19.6%) than cancer patients (12.2%) (p<0.05). The prevalence rate of S. stercoralis among patients receiving chemotherapy and those treated with corticosteroids were 4.3% and 5.2%, respectively. The prevalence rate of S. stercoralis infection was significantly higher in older patients (p<0.05).
CONCLUSIONS
Strongyloidiasis is one of the most common parasites among patients receiving immunosuppressive drugs in northern Iran. Early diagnosis and proper treatment of these patients are necessary to minimize the complications of severe strongyloidiasis.
5.Strongyloides stercoralis and other intestinal parasites in patients receiving immunosuppressive drugs in northern Iran: a closer look at risk factors
Leila MIRZAEI ; Keyhan ASHRAFI ; Zahra ATRKAR ROUSHAN ; Mohammad Reza MAHMOUDI ; Irandokht SHENAVAR MASOOLEH ; Behnaz RAHMATI ; Farshid SAADAT ; Hamed MIRJALALI ; Meysam SHARIFDINI
Epidemiology and Health 2021;43(1):e2021009-
OBJECTIVES:
The objective of this study was to evaluate the prevalence of Strongyloides stercoralis and other intestinal parasites in patients receiving immunosuppressive drugs in northern Iran and to investigate related risk factors.
METHODS:
This cross-sectional study was conducted among 494 patients receiving immunosuppressive drugs, including cancer patients undergoing chemotherapy (n=188) and those treated with prolonged corticosteroid administration (n=306). All fresh fecal samples were examined using the direct wet-mount, formalin ethyl acetate concentration, and agar plate culture techniques.
RESULTS:
In total, 16.8% of patients were positive for at least 1 intestinal parasite; the helminthic and protozoan infection rates were 5.1% and 12.3%, respectively. The infection rate was significantly higher in corticosteroid-treated individuals (19.6%) than cancer patients (12.2%) (p<0.05). The prevalence rate of S. stercoralis among patients receiving chemotherapy and those treated with corticosteroids were 4.3% and 5.2%, respectively. The prevalence rate of S. stercoralis infection was significantly higher in older patients (p<0.05).
CONCLUSIONS
Strongyloidiasis is one of the most common parasites among patients receiving immunosuppressive drugs in northern Iran. Early diagnosis and proper treatment of these patients are necessary to minimize the complications of severe strongyloidiasis.
6.Promising improvement in infected Wound Healing in Type two Diabetic rats by Combined effects of conditioned medium of human adipose‑derived stem cells plus Photobiomodulation
Kaysan SOHRABI ; Houssein AHMADI ; Abdollah AMINI ; Behnaz AHRABI ; Atarodalsadat MOSTAFAVINIA ; Hamidreza OMIDI ; Mansooreh MIRZAEI ; Fatemeh Fadaei FATHABADY ; Mohammadjavad FRIDONI ; Maryam RAHMANNIA ; Sufan CHIEN ; Mohammad BAYAT
Laboratory Animal Research 2023;39(4):356-370
Background:
We aimed to examine the accompanying and solo impacts of conditioned medium of human adiposederived stem cells (h-ASC-COM) and photobiomodulation (PBM) on the maturation stage of an ischemic infected delayed-healing wound model (IIDHWM) of rats with type 2 diabetes (TIIDM).
Results:
Outcomes of the wound closure ratio (WCR) results, tensiometrical microbiological, and stereological assessment followed almost identical patterns. While the outcomes of h-ASC-COM + PBM, PBM only, and h-ASCCOM only regimes were significantly better for all evaluated methods than those of group 1(all, p < 0.001), PBM alone and h-ASC-COM + PBM therapy achieved superior results than h-ASC-COM only (ranged from p = 0.05 to p < 0.001). In terms of tensiometrical and stereological examinations, the results of h-ASC-COM + PBM experienced better results than the PBM only (all, p < 0.001).
Conclusions
h-ASC-COM + PBM, PBM, and h-ASC-COM cures expressively accelerated the maturation stage in the wound healing process of IIDHWM with MRSA in TIIDM rats by diminishing the inflammatory reaction, and the microbial flora of MRSA; and increasing wound strength, WCR, number of fibroblasts, and new blood vessels. While the h-ASC-COM + PBM and PBM were more suitable than the effect of h-ASC-COM, the results of h-ASCCOM + PBM were superior to PBM only.
7.Melatonin and Breast Cancer: A Review Article
Alireza Nemati MOTEHAVER ; Fateme SHEIDA ; Seyed Alireza JAVADINIA ; Behnaz BEHZADI ; Saeid AFSHAR ; Ali KHEZRIAN ; Mostafa GANJURI ; Shadi ESLAH ; Parisa MOKHLES ; Zahra Keshtpour AMLASHI ; Mohammad Esmaeil AKBARI
Chonnam Medical Journal 2025;61(2):63-74
Breast cancer is one of the most common causes of death all over the world. Therapeutic options applied to the patients include surgery, chemotherapy, and radiotherapy.However, far advanced disease often leads to chemoresistance and toxicity. Innovative therapies are needed to address these challenges. Melatonin has the potential to prevent and treat cancer, as it has been revealed in numerous clinical studies. Melatonin is a nontoxic agent that is mostly produced in the pineal gland, inducing various mechanisms of action such as the induction of apoptosis, antiangiogenic, antiproliferative, and metastasis-inhibitory effects. Therefore, melatonin increases therapeutic sensitivity when combined with conventional medication in breast cancer. Melatonin (3-20 mg/day) may reduce breast cancer cell growth in preclinical studies and enhance chemotherapy efficacy. Small human trials suggest potential benefits, but larger studies are needed. Higher doses (≥20 mg/day) are sometimes used alongside chemotherapy. This manuscript reviews research that has demonstrated the antitumor properties of melatonin, thereby focusing on its actions on angiogenesis, apoptosis, metastasis, and antiproliferative properties. We also discuss recent advances in the understanding of the actions of melatonin on epigenetic mechanisms (especially DNA methylation) and telomere length. The data in this review were obtained from journal articles up to May 2024.Regarding the study, Google Scholar and ScienceDirect were used as engines to search for open access. We searched the ISI, Pubmed and Scopus as valid external databases, and as internal databases, ISC and Iran medex. By finding mean keywords such as ‘breast cancer’, ‘estrogen’, ‘melatonin’, ‘cell death’, ‘cell proliferation’, ‘telomerase’ and ‘DNA methylation’, we reached to the formula with maximum collectivity in searching, then equivalent terms were found by Mesh database. The review also covers recent clinical investigations of melatonin in breast cancer.
8.Melatonin and Breast Cancer: A Review Article
Alireza Nemati MOTEHAVER ; Fateme SHEIDA ; Seyed Alireza JAVADINIA ; Behnaz BEHZADI ; Saeid AFSHAR ; Ali KHEZRIAN ; Mostafa GANJURI ; Shadi ESLAH ; Parisa MOKHLES ; Zahra Keshtpour AMLASHI ; Mohammad Esmaeil AKBARI
Chonnam Medical Journal 2025;61(2):63-74
Breast cancer is one of the most common causes of death all over the world. Therapeutic options applied to the patients include surgery, chemotherapy, and radiotherapy.However, far advanced disease often leads to chemoresistance and toxicity. Innovative therapies are needed to address these challenges. Melatonin has the potential to prevent and treat cancer, as it has been revealed in numerous clinical studies. Melatonin is a nontoxic agent that is mostly produced in the pineal gland, inducing various mechanisms of action such as the induction of apoptosis, antiangiogenic, antiproliferative, and metastasis-inhibitory effects. Therefore, melatonin increases therapeutic sensitivity when combined with conventional medication in breast cancer. Melatonin (3-20 mg/day) may reduce breast cancer cell growth in preclinical studies and enhance chemotherapy efficacy. Small human trials suggest potential benefits, but larger studies are needed. Higher doses (≥20 mg/day) are sometimes used alongside chemotherapy. This manuscript reviews research that has demonstrated the antitumor properties of melatonin, thereby focusing on its actions on angiogenesis, apoptosis, metastasis, and antiproliferative properties. We also discuss recent advances in the understanding of the actions of melatonin on epigenetic mechanisms (especially DNA methylation) and telomere length. The data in this review were obtained from journal articles up to May 2024.Regarding the study, Google Scholar and ScienceDirect were used as engines to search for open access. We searched the ISI, Pubmed and Scopus as valid external databases, and as internal databases, ISC and Iran medex. By finding mean keywords such as ‘breast cancer’, ‘estrogen’, ‘melatonin’, ‘cell death’, ‘cell proliferation’, ‘telomerase’ and ‘DNA methylation’, we reached to the formula with maximum collectivity in searching, then equivalent terms were found by Mesh database. The review also covers recent clinical investigations of melatonin in breast cancer.
9.Melatonin and Breast Cancer: A Review Article
Alireza Nemati MOTEHAVER ; Fateme SHEIDA ; Seyed Alireza JAVADINIA ; Behnaz BEHZADI ; Saeid AFSHAR ; Ali KHEZRIAN ; Mostafa GANJURI ; Shadi ESLAH ; Parisa MOKHLES ; Zahra Keshtpour AMLASHI ; Mohammad Esmaeil AKBARI
Chonnam Medical Journal 2025;61(2):63-74
Breast cancer is one of the most common causes of death all over the world. Therapeutic options applied to the patients include surgery, chemotherapy, and radiotherapy.However, far advanced disease often leads to chemoresistance and toxicity. Innovative therapies are needed to address these challenges. Melatonin has the potential to prevent and treat cancer, as it has been revealed in numerous clinical studies. Melatonin is a nontoxic agent that is mostly produced in the pineal gland, inducing various mechanisms of action such as the induction of apoptosis, antiangiogenic, antiproliferative, and metastasis-inhibitory effects. Therefore, melatonin increases therapeutic sensitivity when combined with conventional medication in breast cancer. Melatonin (3-20 mg/day) may reduce breast cancer cell growth in preclinical studies and enhance chemotherapy efficacy. Small human trials suggest potential benefits, but larger studies are needed. Higher doses (≥20 mg/day) are sometimes used alongside chemotherapy. This manuscript reviews research that has demonstrated the antitumor properties of melatonin, thereby focusing on its actions on angiogenesis, apoptosis, metastasis, and antiproliferative properties. We also discuss recent advances in the understanding of the actions of melatonin on epigenetic mechanisms (especially DNA methylation) and telomere length. The data in this review were obtained from journal articles up to May 2024.Regarding the study, Google Scholar and ScienceDirect were used as engines to search for open access. We searched the ISI, Pubmed and Scopus as valid external databases, and as internal databases, ISC and Iran medex. By finding mean keywords such as ‘breast cancer’, ‘estrogen’, ‘melatonin’, ‘cell death’, ‘cell proliferation’, ‘telomerase’ and ‘DNA methylation’, we reached to the formula with maximum collectivity in searching, then equivalent terms were found by Mesh database. The review also covers recent clinical investigations of melatonin in breast cancer.
10. Visceral leishmaniasis among children in an endemic area of northwestern Iran between 2016 and 2017: An epidemiological study
Hamed BEHNIAFAR ; Vahideh MOIN-VAZIRI ; Seyyed Javad Seyyed TABAEI ; Mehdi MOHEBALI ; Elham KAZEMIRAD ; Mehdi MOHEBALI ; Behnaz AKHOUNDI ; Zabih ZAREI ; Mohammad Kazem SAHARIFI-YAZDI ; Alireza ZAHRAEI-RAMAZANI
Asian Pacific Journal of Tropical Medicine 2019;12(7):306-314
Objective: To clarify the epidemiological aspects of visceral leishmaniasis in Kaleybar and Khoda-Afarin districts, north-west of Iran. Methods: A total of 1 420 human (children under 12 years) samples, 101 domestic dogs samples (Canis familiaris), and 577 female sand fly samples were collected. Sera of human and dogs were tested using the direct agglutination test, and sand flies were identified at species level using the microscopic method. Furthermore, a structured questionnaire was applied to evaluate the correlation between the potential risk factors and the related clinical signs/ symptoms with the human and dogs' seropositivity. Results: Totally, 2.18% of human samples were positive at titers≥: 800; among them, 13 cases (41.94%) were above 1:3 200, and clinical symptoms were observed in all of them except for an 11-year old girl. Anti-Leishmania infantum antibodies were found at titers ≥1: 320 in 9.90% of dogs' samples, half of them had at least one sign of canine visceral leishmaniasis. Moreover, 10 Phlebotomus species were identified in the study areas, and Phlebotomus (Larroussius) major group was the predominant species. There are significant correlations between the presence of anti-Leishmania infantum antibodies and the fever (P<0.001), anemia (P=0.001) and weight loss (P=0.016) in children. On the other hand, significant correlations were revealed between the Leishmania infection and the shelter (P=0.039), cutaneous lesion (P=0.005), lymphadenopathy (P=0.001) and weight loss (P<0.001) in the infected dogs. Conclusions: Visceral Leishmania infection is prevalent in rural areas of Kaleybar and Khoda- Afar districts located in East-Azerbaijan province, therefore active detection and treatment of visceral leishmaniasis cases should not be neglected.